IRIDEX CFO buys 5,100 shares at $0.68

IRIDEX CORP’s chief financial officer increased his direct common stock holdings through a reported open-market purchase.

Rhea-AI Filing Summary

IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased 5,100 shares of common stock on September 10, 2026 at $0.68 per share in an open-market or private transaction. Following this purchase, he directly holds 175,052 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Buyer: 5,100 shares

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 5,100 shs ($3K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,100	$0.68	$3K

Holdings After Transaction: Common Stock — 175,052 shares (Direct)

Key Figures

Shares purchased: 5,100 shares Purchase price per share: $0.68 per share Shares owned after transaction: 175,052 shares

3 metrics

Shares purchased 5,100 shares Common stock purchased by CFO on September 10, 2026

Purchase price per share $0.68 per share Price paid for IRIDEX CORP common stock on September 10, 2026

Shares owned after transaction 175,052 shares Direct common stock holdings of the CFO after the purchase

Key Terms

Rule 10b5-1 trading plan, Common Stock, open-market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Common Stock financial

"purchased 5,100 shares of common stock on September 10, 2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market or private transaction financial

"Purchase in open market or private transaction"

FAQ

What insider transaction did IRIX report for its CFO on September 10, 2026?

IRIDEX CORP reported that its Chief Financial Officer, Romeo R. Dizon, purchased 5,100 shares of IRIX common stock on September 10, 2026 at $0.68 per share in an open-market or private transaction.

How many IRIX shares does the CFO own after the latest Form 4 transaction?

After the reported purchase, Chief Financial Officer Romeo R. Dizon directly owns 175,052 shares of IRIDEX CORP common stock, as stated in the Form 4 data.

Was the September 10, 2026 IRIX insider trade made under a Rule 10b5-1 plan?

No. The Form 4 data indicates that no Rule 10b5-1 trading plan is reported for the September 10, 2026 purchase by IRIDEX CORP’s Chief Financial Officer.

What price did the IRIX CFO pay per share in the latest insider purchase?

Chief Financial Officer Romeo R. Dizon purchased 5,100 shares of IRIDEX CORP common stock at a price of $0.68 per share on September 10, 2026.

Is the reported IRIX CFO ownership direct or indirect?

The Form 4 shows that the Chief Financial Officer’s post-transaction holdings of 175,052 shares of IRIDEX CORP common stock are held with direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 11:54 AM Accepted by SEC EDGAR 09/10/2026 - 11:53 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CALIFORNIA 94043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		P		5,100	A	$0.68	175,052	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)